Search Browse Earnings

Aura Biosciences, Inc. — SlamSEC

Aura Biosciences, Inc.

Nasdaq:AURA

Biological Products, (No Diagnostic Substances)·BOSTON, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$83.7M

FY 2024

Net Income

-$76.4M

FY 2024

EPS (Diluted)

-$1.93

FY 2024

Stock Price

$5.94

-0.2%

2026-03-13

52W Range

$4.34 – $7.73

P/E Ratio

-3.1x

Market Cap

$377.2M

Cash

$41.1M

FY 2024

Total Debt

—

Net Cash

$41.1M

Enterprise Value

$336.1M

Debt / EBITDA

0.5x

FY 2024

EV / EBITDA

-4.0x

Employees

—